Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver
- PMID: 16783480
- DOI: 10.1007/s11095-006-0250-5
Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver
Abstract
Purpose: To assess the uridine diphosphate (UDP)-glucuronosyltransferase (UGT) isozymes involved in the glucuronidation of niflumic acid in human liver.
Methods: The glucuronidation activity of niflumic acid was determined in liver microsomes and recombinant UGT isozymes by incubation of niflumic acid with UDP-glucuronic acid (UDPGA).
Results: Incubation of niflumic acid with liver microsomes and UDPGA produced one peak, which was identified as a glucuronide from mass spectrometric analysis. A study involving a panel of recombinant human UGT isozymes showed that glucuronidation activity was highest in UGT1A1 among the isozymes investigated. The glucuronidation in human liver microsomes (HLMs) followed Michaelis-Menten kinetics with a Km value of 16 microM, which is similar to that found with recombinant UGT1A1. The glucuronidation activity of niflumic acid in microsomes from eight human livers significantly correlated with UGT1A1-catalyzed estradiol 3beta-glucuronidation activity (r=0.78, p<0.05). Beta-estradiol inhibited niflumic acid glucuronidation with an IC50 of 25 microM in HLMs, comparable to that for UGT1A1.
Conclusions: These findings indicate that UGT1A1 is the main isozyme involved in the glucuronidation of niflumic acid in the human liver.
Similar articles
-
Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.Biochem Pharmacol. 2007 May 15;73(10):1683-91. doi: 10.1016/j.bcp.2007.01.030. Epub 2007 Jan 28. Biochem Pharmacol. 2007. PMID: 17343829
-
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.Drug Metab Dispos. 2007 Jul;35(7):1182-7. doi: 10.1124/dmd.107.015347. Epub 2007 Apr 19. Drug Metab Dispos. 2007. PMID: 17446261
-
Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.Drug Metab Dispos. 2003 May;31(5):589-95. doi: 10.1124/dmd.31.5.589. Drug Metab Dispos. 2003. PMID: 12695347
-
Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid.Ther Drug Monit. 2000 Feb;22(1):10-3. doi: 10.1097/00007691-200002000-00002. Ther Drug Monit. 2000. PMID: 10688250 Review.
-
Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.Pharmacol Ther. 2021 Feb;218:107689. doi: 10.1016/j.pharmthera.2020.107689. Epub 2020 Sep 25. Pharmacol Ther. 2021. PMID: 32980440 Review.
Cited by
-
Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).Br J Clin Pharmacol. 2013 Oct;76(4):587-602. doi: 10.1111/bcp.12086. Br J Clin Pharmacol. 2013. PMID: 23362865 Free PMC article. Review.
-
Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes.Eur J Clin Pharmacol. 2007 Feb;63(2):211-6. doi: 10.1007/s00228-006-0241-9. Epub 2007 Jan 3. Eur J Clin Pharmacol. 2007. PMID: 17200831
-
Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.Mol Pharm. 2007 Nov-Dec;4(6):883-94. doi: 10.1021/mp700135a. Mol Pharm. 2007. PMID: 18052087 Free PMC article.
-
Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.Eur J Clin Pharmacol. 2007 Mar;63(3):289-96. doi: 10.1007/s00228-007-0261-0. Epub 2007 Jan 24. Eur J Clin Pharmacol. 2007. PMID: 17245571
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources